HIV vaccine fails during trial

The only vaccine against Human Immuno Virus undergoing trials has proved ineffective, its manufacturer has announced.

Known as Mosaico, the trial was the product of a public-private partnership including the United States government and the Janssen Pharmaceuticals.

HIV is a virus that gradually attacks the immune system, which is our body’s natural defence against illness. AIDS is a syndrome caused by HIV.

The announcement posted on Johnson and Johnson’s website noted that the study’s independent Data and Safety Monitoring Board determined that the regimen was not effective in preventing HIV infection compared to the placebo among study participants.

In light of the DSMB’s determination, the Mosaico clinical trial will be discontinued, it said.

We are disappointed with this outcome and stand in solidarity with the people and communities vulnerable to and affected by HIV,” said the Global Therapeutic Area Head, Vaccines, Janssen Research and Development, LLC, Penny Heaton.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button